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Hybrid sequencingAbstract Single-molecule, real-time sequencing developed by Paciﬁc BioSciences offers longer read
lengths than the second-generation sequencing (SGS) technologies, making it well-suited for
unsolved problems in genome, transcriptome, and epigenetics research. The highly-contiguous
de novo assemblies using PacBio sequencing can close gaps in current reference assemblies and
characterize structural variation (SV) in personal genomes. With longer reads, we can sequence
through extended repetitive regions and detect mutations, many of which are associated with dis-
eases. Moreover, PacBio transcriptome sequencing is advantageous for the identiﬁcation of gene
isoforms and facilitates reliable discoveries of novel genes and novel isoforms of annotated genes,
due to its ability to sequence full-length transcripts or fragments with signiﬁcant lengths. Addition-
ally, PacBio’s sequencing technique provides information that is useful for the direct detection of
base modiﬁcations, such as methylation. In addition to using PacBio sequencing alone, many hybrid
sequencing strategies have been developed to make use of more accurate short reads in conjunction
with PacBio long reads. In general, hybrid sequencing strategies are more affordable and scalable
especially for small-size laboratories than using PacBio Sequencing alone. The advent of PacBio
sequencing has made available much information that could not be obtained via SGS alone.Introduction
While the second-generation sequencing (SGS) technologies
have offered vast improvements over Sanger sequencing, their
limitations, especially their short read lengths, make them
poorly suited for some particular biological problems,including assembly and determination of complex genomic
regions, gene isoform detection, and methylation detection.
Single-molecule real-time (SMRT) sequencing, developed by
Paciﬁc BioSciences (PacBio), offers an alternative approach
to overcome many of these limitations. To be concise, it
is referred to as ‘‘PacBio sequencing” hereinafter, though
‘‘SMRT sequencing” is also used by the community.
Unlike SGS, PacBio sequencing is a method for real-time
sequencing and does not require a pause between read steps
[1]. These features distinguish PacBio sequencing from SGS,
so it is classiﬁed as the third-generation sequencing (TGS).
Here we will summarize the mechanisms and performance of
PacBio sequencing. PacBio sequencing offers much longernces and
Figure 2 A single SMRT cell
Each SMRT cell contains 150,000 ZMWs. Approximately 35,000–
75,000 of these wells produce a read in a run lasting 0.5–4 h,
resulting in 0.5–1 Gb of sequence. The image is adapted with
permission from Paciﬁc Biosciences [3]. ZMW, zero-mode
waveguide.
Rhoads A and Au KF /A Review of PacBio Sequencing 279read lengths and faster runs than SGS methods but is hindered
by a lower throughput, higher error rate, and higher cost per
base. Since the advantages of PacBio sequencing and SGS
are complementary, we will examine hybrid-sequencing strate-
gies that make use of both technologies to overcome the disad-
vantages of each alone. We will also discuss the applications of
PacBio sequencing to various areas of research, including gen-
ome, transcriptome, and epigenetics. While reasonable appli-
cations of PacBio sequencing to genomics research were
initially limited to the ﬁnishing of relatively small microbial
genomes, PacBio sequencing can now be utilized to study
much larger genomes including that of human, thanks to the
new computational techniques and improvements in the
sequencing technology. The long read lengths of PacBio
sequencing also make the technology adept at identiﬁcation
and quantiﬁcation of isoforms, including novel isoforms, par-
ticularly when used in conjunction with SGS. In addition,
by monitoring the time between base incorporations,
PacBio sequencing kinetic allows for the direct detection of
base modiﬁcations, such as N6-methyladenine (m6A) and
N4-methylcytosine (m4C).
Mechanism and performance
PacBio sequencing captures sequence information during the
replication process of the target DNA molecule. The template,
called a SMRTbell, is a closed, single-stranded circular DNA
that is created by ligating hairpin adaptors to both ends of a
target double-stranded DNA (dsDNA) molecule (Figure 1)
[2]. When a sample of SMRTbell is loaded to a chip called a
SMRT cell (Figure 2) [3], a SMRTbell diffuses into a sequenc-
ing unit called a zero-mode waveguide (ZMW), which provides
the smallest available volume for light detection. In each
ZMW, a single polymerase is immobilized at the bottom,
which can bind to either hairpin adaptor of the SMRTbell
and start the replication (Figure 3A) [4]. Four ﬂuorescent-
labeled nucleotides, which generate distinct emission spec-
trums, are added to the SMRT cell. As a base is held by the
polymerase, a light pulse is produced that identiﬁes the base
(Figure 3B) [4]. The replication processes in all ZMWs of a
SMRT cell are recorded by a ‘‘movie” of light pulses, and
the pulses corresponding to each ZMW can be interpreted to
be a sequence of bases (called a continuous long read, CLR).
The latest platform, PacBio RS II, typically produces sequenc-
ing movies 0.5–4 h in length [5]. Because the SMRTbell forms
a closed circle, after the polymerase replicates one strand of theFigure 1 SMRTbell template
Hairpin adaptors (green) are ligated to the end of a double-
stranded DNA molecule (yellow and purple), forming a closed
circle. The polymerase (gray) is anchored to the bottom of a ZMW
and incorporates bases into the read strand (orange). The image is
adapted from [2] with permission from the Oxford University
Press.target dsDNA, it can continue incorporating bases of the
adapter and then the other strand. If the lifetime of the poly-
merase is long enough, both strands can be sequenced multiple
times (called ‘‘passes”) in a single CLR. In this scenario, the
CLR can be split to multiple reads (called subreads) by recog-
nizing and cutting out the adaptor sequences. The consensus
sequence of multiple subreads in a single ZMW yields a circu-
lar consensus sequence (CCS) read with higher accuracy. If a
target DNA is too long to be sequenced multiple times in a
CLR, a CCS read cannot be generated, and only a single sub-
read is output instead. Because PacBio sequencing takes place
in real time, kinetic variation interpreted from the light-pulse
movie can be analyzed to detect base modiﬁcations, such as
methylation [6].
An important advantage of PacBio sequencing is the read
length. While the original PacBio RS system with the ﬁrst gen-
eration of chemistry (C1 chemistry) generated mean read
lengths around 1500 bp [7], the PacBio RS II system with the
current C4 chemistry boasts average read lengths over 10 kb
[5], with an N50 of more than 20 kb (that is, over half of all
data are in reads longer than 20 kb) and maximum read
lengths over 60 kb (Figure 4) [8]. In contrast, the maximum
read length of Illumina HiSeq 2500 is only paired-end 250 bp
(using Rapid Run Mode) [9]. The short read lengths of SGS
are commonly unable to span repetitive regions with at least
one unique ﬂanking sequence. In these cases, the origin of a
read cannot be precisely determined. The consequent multiple
alignments and misalignments lead to problems in downstream
analysis, including the abundance estimation and the struc-
tural variation (SV) calling. Because of the much longer read
lengths of PacBio sequencing, the precise location and
sequence of repetitive regions can often be resolved by unique
Figure 4 PacBio RS II read length distribution using P6-C4 chemistry
Data are based on a 20 kb size-selected E. coli library using a 4-h movie. Each SMRT cell produces 0.5–1 billion bases. The P6-C4
chemistry is currently the most advanced sequencing chemistry offered by PacBio. The ﬁgure is adapted with permission from Paciﬁc
Biosciences [8].
Figure 3 Sequencing via light pulses
A. A SMRTbell (gray) diffuses into a ZMW, and the adaptor binds to a polymerase immobilized at the bottom. B. Each of the four
nucleotides is labeled with a different ﬂuorescent dye (indicated in red, yellow, green, and blue, respectively for G, C, T, and A) so that
they have distinct emission spectrums. As a nucleotide is held in the detection volume by the polymerase, a light pulse is produced that
identiﬁes the base. (1) A ﬂuorescently-labeled nucleotide associates with the template in the active site of the polymerase. (2) The
ﬂuorescence output of the color corresponding to the incorporated base (yellow for base C as an example here) is elevated. (3) The dye-
linker-pyrophosphate product is cleaved from the nucleotide and diffuses out of the ZMW, ending the ﬂuorescence pulse. (4) The
polymerase translocates to the next position. (5) The next nucleotide associates with the template in the active site of the polymerase,
initiating the next ﬂuorescence pulse, which corresponds to base A here. The ﬁgure is adapted from [4] with permission from The American
Association for the Advancement of Science.
280 Genomics Proteomics Bioinformatics 13 (2015) 278–289regions within a single read. Although there exist a few
extremely-large repetitive regions that are longer than PacBio
reads, they could be resolvable with enough heterogeneity [10].However, compared to SGS, the throughput of PacBio
sequencing is a drawback. There are 150,000 ZMWs on a sin-
gle SMRT cell, each of which can produce one subread or CCS
Rhoads A and Au KF /A Review of PacBio Sequencing 281read. Typically, only 35,000–70,000 of the 150,000 ZMW wells
on a SMRT cell produce successful reads [11], due to either the
failure to anchor a polymerase or the loading of more than one
DNA molecule in a ZMW. Typical throughput of the PacBio
RS II system is 0.5–1 billion bases per SMRT cell [8]. The
entire workﬂow—from template preparation to primary base
call analysis—takes less than one day. Although the PacBio
RS II generates nearly 10 times the sequence data as the old
PacBio RS system with the C1 chemistry [7], it does not yet
provide the high throughput offered by SGS techniques, such
as Illumina HiSeq 2500. Using the new HiSeq SBS v4 reagent
kits, Illumina HiSeq 2500 produces up to 8 billion paired-end
125 bp reads (1 trillion bases) per two ﬂow cells over a 6-day
run, resulting in a daily throughput of 167 billion bases
(using High Output Run Mode) [9].
Another notable weakness of PacBio sequencing is that the
error rate of a CLR is relatively high (around 11%–15%) [12].
Because the errors are distributed randomly in CLRs, the error
rate can be reduced by generating CCS reads with sufﬁcient
sequencing passes. A coverage of 15 passes yields >99% accu-
racy [4]. However, the number of sequencing passes and the
CCS read length are a trade-off, given that the total length
of a CLR is limited by the life time of the polymerase [13]. That
is, longer sequences yield fewer passes in a CLR, and thus
lower accuracy, and vice versa.
Strengths and weaknesses of SGS and PacBio sequencing
are complementary, which motivated an innovative strategy,
hybrid sequencing, to integrate both techniques. These
approaches often involve using the high-throughput and
high-accuracy short read data to correct errors in the long
reads, in order to reduce the required amount of more costly
long-read sequence data and to salvage the relatively long,
but more error-prone, subreads. Furthermore, PacBio long
reads can provide reliable alignments, scaffolds, and rough
detections of genomic variants, while short reads reﬁne the al
ignments/assemblies/detections to single-nucleotide resolution.
The high coverage of SGS data can also be utilized in down-
stream quantitative analysis.
Overall, PacBio sequencing provides very long reads with a
high error rate and low throughput. Its relative performance
compared to ﬁrst, second, and third generation sequencing
platforms is shown in Table 1 [5,9,12,14–27]. PacBio RS II,
using the sixth generation of polymerase and the fourth gener-
ation of chemistry (P6-C4 chemistry), provides longer average
read length than SGS platforms, but it has a higher single-pass
error rate and lower yield. Moreover, PacBio sequencing is
also faster but more costly than most other methods.Table 1 Performance comparison of sequencing platforms of various g
Method Generation Read length (bp)
Sanger ABI 3730l 1st 600–1000
Ion Torrent 2nd 200
454 (Roche) GS FLX+ 2nd 700
Illumina HiSeq 2500 (High Output) 2nd 2  125
Illumina HiSeq 2500 (Rapid Run) 2nd 2  250
SOLiD 5500l 2nd 2  60
PacBio RS II: P6-C4 3rd 1.0–1.5  104 on average
Oxford Nanopore MinION 3rd 2–5  103 on averageApplications to genome research
De novo assembly
De novo genome assembly is one of the main applications of
PacBio sequencing because long reads can provide large scaf-
folds. PacBio long reads overcome many limitations of genome
assembly using SGS data, such as the presence of highly-
repetitive genomic regions. Though the error rate of PacBio
data is higher than that of SGS, increased coverage or hybrid
sequencing could greatly improve the accuracy. The attempts
of de novo genome assembly using PacBio data started from
small targets, such as microbial genomes. The hierarchical
genome-assembly process (HGAP) developed by Chen et al.
generates de novo assemblies using PacBio sequencing data
from a single, long-insert shotgun DNA library [28]. In addi-
tion, a few methods using hybrid sequencing data, including
ALLPATHS-LG, PacBio Corrected Reads pipeline, SPAdes,
and SSPACE-LongRead, have been applied to complete bacte-
rial genome assemblies [29]. Table 2 provides a list of selected
de novo assemblies produced using PacBio sequencing alone or
using hybrid sequencing, along with some of their noteworthy
achievements [7,30–35].
The beneﬁts of PacBio sequencing are apparent in the
de novo assembly produced by Brown et al., who compared
PacBio sequencing to Illumina, 454, and Illumina/454 hybrid
assemblies in ﬁnishing the 100-contig draft genome of Clostrid-
ium autoethanogenum DSM 10061 [7]. C. autoethanogenum is
an acetogen that is capable of producing ethanol from carbon
monoxide, and it is therefore of great biotechnological interest.
Its genome has a 31.1% GC content and contains repeats,
prophage, and nine copies of the rRNA gene operons, so it
is classiﬁed as a Class III genome, the most complex genome
classiﬁcation in terms of repeat content and repeat type [7].
Using only one PacBio library preparation and two SMRT
cells, the entire genome could be assembled de novo in a single
contig, despite the complexity of the C. autoethanogenum gen-
ome. No method based on SGS data could assemble the gen-
ome in less than 22 contigs, and each of the SGS assemblies
contained at least four collapsed repeat regions, while the
PacBio assembly had none [7].
In addition, a de novo assembly of the Potentilla micrantha
chloroplast genome using PacBio sequencing covered the
entire 154,959 bp of the chloroplast genome in a single contig
[33]. This offered an improvement over the Illumina assembly,











0.001 96 0.5–3 h 500 [14,18–21]
1 8.2  107 2–4 h 0.1 [15,25]
1 1  106 23 h 8.57 [14,17,27]
0.1 8  109 (paired) 7–60 h 0.03 [9,16,26]
0.1 1.2  109 (paired) 1–6 days 0.04 [9,16,26]
5 8  108 6 days 0.11 [14,24]
13 3.5–7.5  104 0.5–4 h 0.40–0.80 [5,12,15]
38 1.1–4.7  104 50 h 6.44–17.90 [22,23]
Table 2 De novo genome assemblies using hybrid sequencing or PacBio sequencing alone
Species Method Tools SMRT cells Coverage Contigs Achievements Ref.
Clostridium autoethanogenum PacBio HGAP 2 179 1 21 fewer contigs than using SGS; no




PacBio HGAP, Celera, minimus2,
SeqMan
26 320 1 6 fewer contigs than with Illumina; 100%
coverage (Illumina: 90.59%); resolved 187
ambiguous nucleotides in Illumina
assembly; unambiguously assigned small
diﬀerences in two >25 kb inverted
repeats
[33]
Escherichia coli PacBio PBcR, MHAP, Celera,
Quiver
1 85 1 4.6 CPU hours for genome assembly (10
improvement over BLASR)
[31]
Saccharomyces cerevisiae PacBio PBcR, MHAP, Celera 12 117 21 27 CPU hours for genome assembly (8
improvement over BLASR); improved
current reference of telomeres
[31]
Arabidopsis thaliana PacBio PBcR, MHAP, Celera 46 144 38 1896 CPU hours for genome assembly [31]
Drosophila melanogaster PacBio PBcR, MHAP, Celera,
Quiver
42 121 132 1060 CPU hours for genome assembly
(593 improvement over BLASR);
improved current reference of telomeres
[31]
Homo sapiens (CHM1htert) PacBio PBcR, MHAP, Celera 275 54 3434 262,240 CPU hours for genome assembly;
potentially closed 51 gaps in GRCh38;
assembled MHC in 2 contigs (60 contigs
with Illumina); reconstructed repetitive
heterochromatic sequences in telomeres
[31]
Homo sapiens (CHM1tert) PacBio BLASR, Celera, Quiver 243 41 N/A
(local assembly)
Closed 50 gaps and extended into 40
additional gaps in GRCh37; added over
1 Mb of novel sequence to the genome;
identiﬁed 26,079 indels at least 50 bp in
length; cataloged 47,238 SV breakpoints
[32]
Melopsittacus undulatus Hybrid PBcR, Celera 3 5.5 PacBio + 15.4 454
= 3.83 corrected
15,328 1st assembly of >1 Gb parrot genome;
N50 = 93,069
[34]
Vibrio cholerae Hybrid BLASR, Bambus, AHA 195 200 PacBio + 28 Illumina
+ 22 454
2 No N’s in contigs; 99.99% consensus
accuracy; N50 = 3.01 Mb
[30]
Helicobacter pylori PacBio HGAP, Quiver, PGAP 8 per strain 446.5 average among strains 1 per strain 1 complete contig for each of 8 strains;
methylation analysis associated motifs
with genotypes of virulence factors
[35]
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regions and resolved 187 ambiguities in the Illumina assembly,
including long inverted repeat regions that are characteristic of
chloroplast genomes.
In contrast to relatively small genomes, the assembly of
large genomes by overlapping sequence reads can be more
computationally expensive. In order to overcome this obstacle,
Berlin et al. developed the MinHash Alignment Process
(MHAP) for efﬁcient overlapping of noisy long reads [31].
MHAP creates a compact representation of sequencing reads
by utilizing a dimensionality reduction technique called
MinHash [36]. Compared to BLASR, another aligner that is
capable of overlapping PacBio reads [37], MHAP efﬁciently
constructed comparable or improved de novo assemblies of
the human genome and the genomes of four model organisms
(Escherichia coli, Saccharomyces cerevisiae, Arabidopsis thali-
ana, and Drosophila melanogaster) using PacBio sequencing
without SGS short reads. In particular, this method resulted
in a 600-times faster assembly for D. melanogaster. This assem-
bly contained only 132 contigs, and it potentially resolved
52 of the 124 gaps in the version 5 reference genome of
D. melanogaster.
The haploid human genome assembly by MHAP is highly
contiguous and potentially closes 51 of 819 gaps in GRCh38
[31]. As an example of a difﬁcult region to assemble, the major
histocompatibility complex (MHC), which has an important
role in immunity, was broken into over 60 contigs in the Illu-
mina assembly, while 97% of the region was assembled in just
two contigs using PacBio sequencing. PacBio long reads also
allowed for the reconstruction of repetitive heterochromatic
sequences in telomeric regions. In humans, the loss of telom-
eres has been associated with diseases, including premature
aging syndromes and cancer [38]. PacBio sequencing offers
an improvement over current reference genomes, in which
telomeric regions are poorly annotated, which will improve
the study of telomere-associated diseases.
In 2015, another de novo assembly of a haploid human gen-
ome by Chaisson et al. closed 50 of the 164 gaps in GRCh37
and shortened 40 other gaps [32]. 39 of the 50 closed gaps
included short tandem repeats (STRs) in GC-rich regions.
STRs are repetitive elements of 2–6 nucleotides that are gener-
ally not sequenceable beyond 100 bp by SGS. This assembly
also identiﬁed 47,238 breakpoint positions, resolving 26,079
euchromatic structural variations (SVs) at the single-
nucleotide resolution, including inversions, complex insertions,
and repetitive regions.
As alternatives to using PacBio sequencing alone for
eukaryotic de novo assemblies, error correction strategies using
hybrid sequencing have also been developed. Koren et al.
developed the PacBio corrected Reads (PBcR) approach for
using short reads to correct the errors in long reads [34]. PBcR
has been applied to the previously-unsequenced parrot (Melop-
sittacus undulatus) genome using 5.5 coverage of PacBio
reads that were corrected by 15.4 coverage of 454 reads,
yielding 3.83 coverage of corrected reads. The error correc-
tion required 6.8 days to complete. The >1 Gb assembly con-
sisted of 15,328 contigs, with an N50 of 93,069 bp. Also,
Bashir et al. used hybrid sequencing data to assemble the gen-
ome of a recent Haitian cholera outbreak strain at >99.9%
accuracy in two nearly ﬁnished contigs, completely resolving
complex regions with clinically relevant structures [30].Using the direct sequencing protocol without constructing a
library, PacBio data can be generated from as little as 1 ng of
DNA, while typical protocols require 400–500 ng of sheared
DNA for library preparation [39]. At the cost of reducing
the yield per SMRT cell to around 3000 reads, which limits
its utility to small genomes, this method allows PacBio data
to be generated within eight hours of receiving the sample, less
than half the time required when library preparation is
included. This approach has been applied to sequence antibi-
otic resistance gene-carrying bacterial plasmids, plasmid vector
models for analysis of DNA-modiﬁcation, linear DNA frag-
ments covering an entire bacterial genome, and single- or
double-stranded viral genomes [39]. Because it requires no a
priori knowledge of any sequence or organism-speciﬁc reagents
but offers the high speed and low DNA requirement of direct
sequencing, this method could be applicable to sequence plas-
mids, viruses, mitochondrial DNA, and microbial pathogens
in a clinical setting.
Problematic genomic regions
Closing gaps in draft genomes can also be accomplished efﬁ-
ciently via PacBio sequencing of PCR products. This approach
is more cost-effective than Sanger sequencing and is able to
close gaps greater than 2.5 kb in a single round of reactions
[40]. However, a loading bias against larger PCR products is
present since smaller PCR products load into the ZMWs with
greater efﬁciency. This bias can be reduced if the molar ratio of
the PCR products is adjusted according to their size and con-
centration when pooling them together. Zhang et al. compared
this gap closure method with Sanger sequencing for 362 gaps
ranging from 500 bp to 5 kb from 16 diverse genomes [40].
Of gaps smaller than 2.5 kb, 64% and 73% were closed by
Sanger and PacBio sequencing, respectively, while none of
the gaps larger than 2.5 kb were closed by Sanger sequencing,
compared to 88% by PacBio sequencing. They also found that
only the PacBio platform could sequence through small hair-
pin structures (called hard stops) and that the PacBio platform
performed better in high GC regions compared to Sanger
sequencing.
STRs are associated with many genetic disorders and are
difﬁcult to detect with SGS technologies. One such gene is
the human fragile X mental retardation 1 (FMR1) gene.
FMR1 contains a (CGG)n repeat that is responsible for herita-
ble disorders including fragile X syndrome, fragile
X-associated tremor/ataxia syndrome, adult-onset neurode-
generative disorder, premature ovarian insufﬁciency, learning
disabilities, autism spectrum disorders, attention deﬁcit hyper-
activity disorder, and seizures [41]. There are normally 7–60
(CGG) repeats, while the permutation range is 60–230 repeats,
and the full mutation range is over 230 repeats [42]. Loomis
et al. generated PacBio long reads for expanded CGG-repeat
FMR1 alleles in full mutation range [41]. They demonstrated
that PacBio sequencing was not adversely affected by expan-
sions exceeding 750 repeats, suggesting that productive
sequencing is limited only by factors governing the productive
lifetime of the polymerase and the desired number of subreads
within an individual CCS read. PacBio targeted sequencing has
also been used to resolve the genomic gap in MUC5AC [43],
which encodes a large, secreted mucin that is important in
cystic ﬁbrosis, lung cancer, and respiratory diseases [44]. By
284 Genomics Proteomics Bioinformatics 13 (2015) 278–289sequencing PCR products covering the central exon, SVs
among four individuals were also characterized [43].
While the examination of STRs in FMR1 and MUC5AC
made use of PacBio sequencing alone, Doi et al. developed a
method for rapidly ﬁnding long STRs in personal genomes
using hybrid sequencing [45]. They applied this method to
locate an STR associated with the brain disease, spinocerebel-
lar ataxia 31 (SCA31). Using PacBio sequencing targeting this
site, they revealed that the instability of the repeat expansions
associated with SCA31 is determined by (TGGAA) and
(TAAAATAGAA) repeats.
These successful applications indicate the promising utility
of PacBio sequencing for the study of other diseases, such as
myotonic dystrophy, Huntington’s disease, Friedreich’s ataxia,
and amyotrophic lateral sclerosis-frontal temporal dementia
(ALS-FTLD), which are all associated with repeat expansions
[41]. In contrast to SGS, PacBio sequencing is able to obtain
information from individuals with expanded STRs and could
likely be developed as a diagnostic approach.Characterization of structural variation
Compared to SNPs, large structural variations (SVs), such as
copy-number variations (CNVs), copy-number neutral inver-
sions, mobile-element insertions (MEIs), deletions, transloca-
tions, and combinations of these events, are more
challenging to detect and characterize. Characterization of
SVs is crucial to the study of many diseases, including cancer
[46,47]. Up to 13% of the human genome is subject to SVs
[48], which account for a majority of variant bases. In the
Sanger-sequenced diploid genome of an individual human,
74% of a total of 12.3 Mb of variant bases were SVs [49].
However, due to the short sequencing length, the SGS
approaches impose severe limitations on the study of these
complex SVs, particularly those involving repetitive regions.
PacBio sequencing is based on single-molecule sequencing
technology and provides much longer reads. Thus, it is adept
at identifying non-SNP DNA variations, albeit at the cost of
higher per-nucleotide error rates. In 2014, a SV detection tool,
MultiBreak-SV, was developed to analyze PacBio sequencing
data, paired-end short reads, or hybrid sequencing data [50].
Ritz et al. demonstrated that MultiBreak-SV is able to detect
SVs with high sensitivity and speciﬁcity by applying to PacBio
data from four human fosmids. They also predicted 1002 SVs
in a hydatidiform mole genome (CHM1tert) using PacBio
data, over half of which were conﬁrmed by an Illumina
assembly [50].
Cancer development has been attributed to SVs including
large chromosomal rearrangements, duplications, and dele-
tions. While recurring SVs may be viable biomarkers for dis-
ease detection and prognosis, they are difﬁcult to monitor
when the breakpoint of the SV is unknown. In many cases,
such as the CDKN2A deletion, which diminishes expression
of multiple tumor-suppressor proteins, the breakpoints may
vary between individuals [46]. Patel et al. developed Ampliﬁca-
tion of Breakpoints (AmBre), a pipeline to identify DNA
breakpoints associated with known translocations and dele-
tions using PacBio sequencing [46]. Using AmBre, they discov-
ered CDKN2A deletion breakpoints in six cancer cell lines,
including MCF7, for which previous studies have failed toannotate the CDKN2A breakpoints, likely due to repetitive
sequences [46,51,52].
The ﬁrst long-read characterization of SV in a personal
diploid human genome has been recently performedwith Parlia-
ment, a consensus SV-calling infrastructure that utilizes multi-
ple SV detection methods and data types, including PacBio
long reads [48]. Parliament identiﬁed over 31,007 genomic loci
ranging between 100 bp and 1 Mb from a single individual
(HS1011) that deviated from the hg19 reference assembly.
Among them, 9777 loci, which span 59 Mb of the reference gen-
ome (1.8%), were corroborated as SVs by PacBio sequencing,
local hybrid sequencing, or multi-source heuristics. Of these
9777 loci, 3801 loci were identiﬁed only by long-read data.
Applications to transcriptome research
Transcript sequencing using Iso-Seq
Understanding the complete expression of gene isoforms (i.e.,
transcripts) is fundamental for transcriptome studies. While
SGS is frequently used for gene proﬁling, it is often unable
to identify full-length gene isoforms and can introduce ampli-
ﬁcation bias. SGS faces particularly severe limitations on tran-
script recall and splice product discrimination in the context of
complex eukaryotic genomes. An assessment of SGS methods
for transcript reconstruction found that expression level
estimates varied widely across methods, even when based on
similar transcript models [53]. Because PacBio sequencing
produces longer reads, it can be used to more comprehensively
identify transcripts.
Paciﬁc Biosciences developed a protocol, Iso-Seq, for tran-
script sequencing, including library construction, size selection,
sequencing data collection, and data processing. Iso-Seq
allows direct sequencing of transcripts up to 10 kb without
use of a reference genome [54]. The experimental component
of Iso-Seq is to select and sequence full-length transcripts,
and the following data processing step generates the highest-
quality reads of each selected transcript, called ‘‘Reads of
Insert.” Iso-Seq has been used to characterize alternative splic-
ing events involved in the formation of blood cellular compo-
nents [55]. This is critical for interpreting the effects of
mutations leading to inherited disorders and blood cancers,
and can be applied to design strategies to advance transplanta-
tion and regenerative medicine. In addition, using PacBio
sequencing on the polyadenylated RNA complement of 20
human organs and tissues, Sharon et al. obtained 476,000
CCS reads and identiﬁed 14,000 spliced GENCODE genes.
Interestingly, over 10% of their alignments represent
previously-unannotated intron structures [56].
Nonetheless, the sensitivity of Iso-Seq method is limited by the
following factors: (1) the selection of full-length transcripts is not
complete, so not all Reads of Insert represent full-length tran-
scripts; (2) very long transcripts are likely not sequenced in full
due to the sequencing length limit; (3) high-quality reads (CCS
reads) can be generated only if the target cDNA is short enough
to be sequenced by multiple passes. As Paciﬁc Biosciences has
been improving the throughput and sequencing movie time, the
limitation could be reduced, though not thoroughly. An alterna-
tive way to overcome this limitation is to integrate SGS short reads
and PacBio long reads via hybrid sequencing.
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Besides genome assembly, hybrid sequencing can also be
applied to the error correction of PacBio long reads of tran-
scripts. Moreover, it could improve gene isoform identiﬁcation
and abundance estimation. Au et al. have developed the tool
LSC for the correction of raw PacBio reads by SGS short
reads [57]. Applying this tool to 100,000 human brain cerebel-
lum PacBio subreads and 64 million 75-bp Illumina short
reads, they reduced the error rate of the long reads by more
than 3-fold. In order to identify and quantify full-length gene
isoforms, they also developed an Isoform Detection and Pre-
diction tool (IDP), which makes use of TGS long reads and
SGS short reads [58]. Applying LSC and IDP to PacBio long
reads and Illumina short reads of the human embryonic stem
cell (hESC) transcriptome, they detected 8084 RefSeq-
annotated gene isoforms at full-length and predicted an addi-
tional 5459 gene isoforms through statistical inference [58].
Compared to Cufﬂinks, a widely-used tool for gene isoform
identiﬁcation and quantiﬁcation based on SGS short reads
[59], IDP had a much higher sensitivity for isoform identiﬁca-
tion (62% true positive for IDP vs. 20% true positive for Cuf-
ﬂinks) at a 5% false positive rate. Over one-third of the 5459
isoforms predicted by IDP were novel, and 273 of these were
transcribed from 216 unannotated gene loci. The improved
identiﬁcation of the hESC transcriptome obtained through
hybrid sequencing will facilitate the development of models
of differentiation and cell commitment within the developing
embryo and a better understanding of the molecular mecha-
nisms involved in the maintenance of pluripotency. IDP-
fusion has also been recently released for the identiﬁcation of
fusion genes, fusion sites, and fusion gene isoforms from can-
cer transcriptomes [60]. In the human MCF7 breast cancer cell
line, IDP-fusion detected fusion genes at a much higher preci-
sion than non-hybrid tools that use TGS alone and SGS alone
(69% true positive for IDP-fusion vs. 31% for TRUP [61],
23% for TopHat-Fusion [62], and 21% for Iso-Seq [54]), with
similar sensitivity.
Personal transcriptomes
Personal transcriptomes are expected to have applications in
understanding individual biology and disease, but SGS has
been shown to be insufﬁciently accurate for the identiﬁcation
and quantiﬁcation of an individual’s genetic variants and gene
isoforms [53,63,64]. Using a hybrid sequencing strategy com-
bining PacBio long reads and Illumina short reads, Tilgner
et al. sequenced the lymphoblastoid transcriptomes of three
family members in order to produce and quantify an enhanced
personalized genome annotation [63]. Around 711,000 CCS
reads were used to identify novel isoforms, and 100 million
Illumina paired-end reads were used to quantify the personal-
ized annotation, which cannot be accomplished by the rela-
tively small amount of long reads alone. This method
produced reads representing all splice sites of a transcript for
most sufﬁciently expressed genes shorter than 3 kb. It provided
a de novo approach for determining single-nucleotide varia-
tions (SNVs), which could be used to improve RNA haplotype
inference. By additionally producing transcriptomes for both
parents, they found that PacBio sequencing improved the
accuracy of personal transcriptomes despite the high error rateof PacBio data. Single molecules can be attributed to the allele
from which they were transcribed, which could also allow for
the assessment of biased allelic or isoform expression.
Applications to epigenetics research
DNA modiﬁcations can inﬂuence a variety of processes in
many organisms, including gene expression, gene silencing,
host–pathogen interactions, and DNA replication, repair,
and transcription regulation [65]. In bacterial genomes,
N6-methyladenine (m6A), N4-methylcytosine (m4C), and 5-
methylcytosine (m5C) function as components of restriction-
modiﬁcation (RM) systems [66–69]. Along with m6A and
m5C, modiﬁed bases such as 5-hydroxymethylcytosine (5-
hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC)
are also present in eukaryotic genomes [68]. However, because
SGS lacks simple methods to determine the locations of most
DNA modiﬁcations, many DNA modiﬁcations have typically
been ignored.
Cytosine methylation is the most widely-studied DNA
modiﬁcation. Bisulﬁte sequencing is the most common high-
throughput sequencing method for genome-wide detection of
these epigenetic events, typically using Illumina short reads
[70]. This method involves treating DNA with a bisulﬁte
reagent that converts unmethylated cytosine to uracil, but it
requires a well-deﬁned reference genome [70]. The sample
preparation steps can be costly and time-consuming, and the
required reaction conditions can degrade DNA [71]. Bisulﬁte
sequencing is also limited to the detection of speciﬁc forms
of methylation that can undergo this conversion [70]. More
importantly, it cannot discriminate between C, m5C, and
5hmC [67].
In contrast to base conversion employed in bisulﬁte
sequencing, PacBio sequencing uses an alternative approach
to directly detect native epigenetic modiﬁcations. It monitors
time between base incorporations in the read strand, called
inter-pulse durations (IPDs). The difference of IPDs between
normal and modiﬁed bases serves as signal to detect base mod-
iﬁcations (Figure 5) [72]. This technique is applicable to the
detection of either DNA or RNA modiﬁcations [73] and over-
comes many of the limitations and burdens of bisulﬁte
sequencing, with unique kinetic characteristics observable for
over 25 types of base modiﬁcations [67]. However, because
the kinetic variation signals produced by m5C modiﬁcations
are very weak, PacBio sequencing is unable to detect m5C
modiﬁcations with high accuracy [66,68].
The resequencing of six bacteria, including
Geobacter metallireducens GS-15, Chromohalobacter
salexigens, Vibrio breoganii 1C-10, Bacillus cereus ATCC
10987, Campylobacter jejuni subsp. jejuni 81-176, and C. jejuni
NCTC 11168, byMurray et al. using PacBio sequencing resulted in
the discovery of new m6A and m4C methylation patterns in each
genome [68]. The m6A and m4C methyltransferases (MTases)
responsible for those patterns were also assigned. This study showed
that PacBio sequencing provides information about not only which
MTase genes are active, but also their recognition sequences by
aligning the methylated bases with their kinetic signatures.
Using kinetic variation data obtained via PacBio sequenc-
ing, Fang et al. detected 49,311 m6A residues and 1407 m5C
residues in a pathogenic E. coli genome [66]. They were also
able to deduce the target sites of MTases that catalyze m6A
Figure 5 Detection of methylated bases using PacBio sequencing
PacBio sequencing can detect modiﬁed bases, including m6A (also known as 6mA), by analyzing variation in the time between base
incorporations in the read strand. The ﬁgure is adapted with permission from Paciﬁc Biosciences [72]. a.u. stands for arbitrary unit.
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alone. In addition, they found that an MTase component of
an RM system affected gene expression and DNA replication,
suggesting that the RM systems function beyond protecting
host genomes from foreign DNA.
The detection of epigenetic motifs using PacBio sequencing
is not limited to settings with complete references or high-
coverage samples. Beckmann et al. have demonstrated the
ability of PacBio sequencing to recover previously-discovered
epigenetic motifs with m6A and m4C modiﬁcations in both
low-coverage and high-contamination scenarios [70]. They
were also able to recover many motifs from three mixed strains
(E. coli, G. metallireducens, and C. salexigens), even when the
motif sequences of the genomes of interest overlap substan-
tially, suggesting that PacBio sequencing is applicable to
metagenomics. They note that hybrid sequencing would be
more cost-effective than using PacBio sequencing alone in
order to detect and accurately deﬁne k-mers for low propor-
tion genomes.
Epigenetic motifs can also be detected in conjunction with
de novo assembly using PacBio sequencing, as was done for
Helicobacter pylori. H. pylori is a bacteria found in stomachs
of about two-thirds of the world’s population that can cause
ulcers and lead to stomach cancer [74]. Its genome is around
1.6 Mb in size with a GC content of 39% and high allelic
diversity. Whole-genome sequencing by PacBio platform of
eight H. pylori strains has recently determined a single, com-
plete contig for each strain through de novo assembly [35].
Moreover, in this study, the methylation information pro-
vided by PacBio sequencing additionally led to the identiﬁca-
tion of epigenetic motifs that were associated with virulence
factors.
In order to increase the detection accuracy of DNA modi-
ﬁcations, and to reduce or eliminate the required coverage of
control data that are free of modiﬁcations, Feng et al. devel-
oped an empirical Bayesian hierarchical model for incorpora-
tion of historical PacBio sequencing data [75]. Because local
sequence context can explain roughly 80% of the variation
in polymerase kinetics near a given incorporation site [75], they
estimate an expected kinetic rate of the polymerase at that
incorporation site using historical data. They demonstrated
that this method can increase detection accuracy at a reduced
sequencing cost by applying their model to detect modiﬁca-
tions in plasmids with known modiﬁed sites and an E. coli
K-12 strain. This model has been implemented in theR package ‘‘seqPatch” (available at https://github.com/
zhixingfeng/seqPatch).
Intercellular heterogeneity, i.e., differential DNA modiﬁca-
tion status between cells in a population, is a major cause of phe-
notypic heterogeneity in many organisms [76]. In order to
quantitatively detect intercellular heterogeneity in genome
DNA modiﬁcations, Feng et al. developed qDNAmod, a bioin-
formatics tool for analysis of PacBio sequencing data [76].
Applying qDNAmod to Streptococcus pneumoniae strain
ST556, Feng et al. determined that four highly-signiﬁcant methy-
lation motifs contained m6A. They mapped these motifs to the
genome and found that the intercellular heterogeneity of the
methylation is mediated by two type I RM systems. Therefore,
their studies demonstrate that investigation of intercellular
heterogeneity in previously undetectable genome DNAmodiﬁca-
tions (such as m6A and m4C) is facilitated by the direct detection
of modiﬁcations in single molecules by PacBio sequencing.
Discussion
In the past years, PacBio sequencing has been applied to de
novo assemble or resequence a variety of genomes (from small
microbe to human), characterize the complexity of transcrip-
tomes at the isoform level, and study base modiﬁcations. A
summary of the advantages and achievements of PacBio
sequencing in recent years is given in Table 3 [7,30–35,40,41,
43,45,46,48,50,55,56,58,60,63,66–68,70,75,76].
In the meantime, a number of relevant bioinformatics tools
have also been developed. As demonstrated by these recent
studies, PacBio sequencing provides an unprecedented oppor-
tunity to overcome many of the obstacles faced by SGS via
providing longer read lengths, kinetic variation information,
and shorter run times, yet the technology still has room for
improvement in other aspects, such as the high error rate of
raw single-pass data. Obtaining sufﬁcient read depth to build
a sufﬁciently-accurate consensus sequence can be costly for
large, complex genomes. On the other hand, obtaining high
coverage for smaller genomes is more affordable. For micro-
bial genomes, 100 coverage is reliable for resolving repetitive
regions and costs less than $1000 with a 20 kb library prepara-
tion [6]. Although PacBio is still outperformed by SGS with
regard to throughput, the sequencing chemistry, protocol
workﬂows, and software continue to improve. One such
improvement will be active loading to increase the rate of suc-




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Rhoads A and Au KF /A Review of PacBio Sequencing 287In the near future, neither PacBio sequencing nor SGS is likely
to be replaced by the other.
As PacBio sequencing and SGS each have their own
strength and weakness, hybrid sequencing has become a more
popular approach to fully make use of the advantages of
both platforms. In particular, hybrid sequencing makes the
cost and work load more acceptable for small-size biomedical
research laboratories compared to PacBio sequencing alone,
and it brings exclusive information that is not available from
SGS. The long-read PacBio data shed light on intractable
problems in SGS, while the research outcome can be quanti-
ﬁed or reﬁned to single-nucleotide resolution via integration
with high-throughput and high-accuracy SGS data.
While PacBio sequencing may coexist with and complement
SGS, it faces the competition from the other developing TGS
technologies, such as Oxford Nanopore Technologies (ONT).
ONT is the second commercialized TGS platform from 2014.
Although only very limited studies and data of ONT have been
published, it shows similar advantages and disadvantages:
ONT reads are long but are of even higher error rate than
PacBio sequencing [22]. However, unlike PacBio’s CCS strat-
egy of repeatedly sequencing a target with many passes to
improve accuracy, ONT is limited to only two passes by
design, so its high error rate is a major disadvantage. While
the read lengths in many of the current studies using ONT
have not surpassed those of PacBio sequencing, ONT could
potentially offer longer average reads than PacBio. On top
of that, ONT MinIONTM is a portable and very small USB
device, which makes it stand out from all existing sequencing
technologies. Moreover, the far lower price ($1000 in ONT
early access program) [78] could make ONT as a routine
experimental measure in biomedical laboratories.
In January of 2015, Dr. Jonas Korlach, Chief Scientiﬁc
Ofﬁcer of Paciﬁc Biosciences, predicted that the throughput
of PacBio sequencing will increase 4-fold in 2015, reaching at
least 4 Gb per SMRT cell run, and that the average read
lengths of PacBio sequencing will reach 15–20 kb during
2015 [77]. In September, the company announced its new
Sequel System, which will feature one million ZMWs per
SMRT cell instead of 150,000 and therefore deliver seven times
more reads per SMRT cell, according to PacBio [79,80]. It will
also offer the ﬂexibility of up to 16 SMRT cells per run [80].
The Sequel System will cost $350,000, less than half the cost
of the PacBio RS II ($750,000), and PacBio CEO Mike
Hunkapiller claims that the system will be able to deliver a
10 human genome in one day at a consumables cost of
$3000 [79]. According to Dan Zabrowski of Roche, which
partnered with Paciﬁc Biosciences to develop the Sequel Sys-
tem, this system will serve as the basis for a series of clinical
platforms in late 2016, paving the way for PacBio sequencing
to be used for diagnostics [79]. Although PacBio sequencing
has shown advantages in some unique niches, the cost and
throughput have previously prevented it from being applied
more broadly since many biomedical researches focus on the
large and complicated human genome. The Sequel System’s
increased throughput and decreased cost have the potential
to remedy this limitation.
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